Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The multidomain-containing cellular protein
BS69
interacts with adenovirus E1A and several other viral and cellular factors, and acts as a transcription repressor. Here, we show that
BS69
is involved in the p53-p21Cip1-mediated senescence pathway. Knockdown of
BS69
by RNA interference in human primary fibroblasts results in elevated levels of p21Cip1 and the appearance of several senescent markers, including enhanced senescence-associated
beta-galactosidase
activity and formation of senescence-associated heterochromatin foci. Importantly, knockdown of either p53 or p21Cip1, but not p16(INK4a) or Rb, allows cells to bypass premature senescence that is induced by
BS69
knockdown. Furthermore, we show that
BS69
forms complexes with both p53 and p400, and that
BS69
associates with the p21Cip1 promoter through p53. Together, our data indicate that
BS69
is involved in cellular senescence mainly through the p53-p21Cip1 pathway.
...
PMID:BS69 is involved in cellular senescence through the p53-p21Cip1 pathway. 1772 38